Nedaplatin/Docetaxel Versus Cisplatin/Docetaxel in Treatment of Advanced/Relapsed Squamous Cell Lung Cancer

The requested reference [b36aa6b67cfa58ea371dff217cbcd6291b1bd394] no longer exists in our database. It has been replaced by the current reference: [fdb7cb983959af102d3e581b85199ac60ae649dd]

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2015
To compare the efficacy and safety of docetaxel plus nedaplatin with docetaxel plus cisplatin in managment of advanced/relapsed squamous cell lung cancer.
Epistemonikos ID: 9b5c2830fdbacace786779a080c38e6c735cd8a6
First added on: May 12, 2024